Clinical Trials in Nashville

Showing 15081-15100 of 20,298 trials

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

NCT01359696

This is an open-label, multicenter, Phase I, dose-escalation study to assess the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD) of GDC-0425 administered with and without gemcitabine.

Solid Tumor

Genentech, Inc.40 participantsStarted Jul 2011

Detroit, Michigan, United States • Nashville, Tennessee, United States • Villejuif, France

COMPLETEDPhase 3< 1 mile

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

NCT00025259

This randomized phase III trial is studying different chemotherapy regimens given with or without radiation therapy to compare how well they work in treating children with newly diagnosed Hodgkin's disease. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Giving the drugs in different combinations may kill more cancer cells. Radiation therapy uses high-energy x-rays to damage cancer cells. It is not yet known if chemotherapy is more effective with or without additional chemotherapy and/or radiation therapy in treating Hodgkin's disease.

Childhood Lymphocyte-Depleted Classical Hodgkin LymphomaChildhood Mixed Cellularity Classical Hodgkin LymphomaChildhood Nodular Lymphocyte Predominant Hodgkin Lymphoma+5 more

Children's Oncology Group1,734 participantsStarted Sep 2002

Birmingham, Alabama, United States • Phoenix, Arizona, United States • Little Rock, Arkansas, United States +172 more locations

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0425 Administered With and Without Gemcitabine in Patients With Refractory Solid Tumors or Lymphoma

Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease

Find Trials by Condition in Nashville

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Thrombin Regulated Platelet Activation

Expressive Writing in Improving Quality of Life in Patients With Breast Cancer and Lymphedema

A Study of Varlilumab (Anti-CD27) and Ipilimumab and CDX-1401 in Patients With Unresectable Stage III or IV Melanoma

Biomagnetic Characterization of Gastric Dysrhythmias:Study 2

Effect of NovoTTF-100A Together With Temozolomide in Newly Diagnosed Glioblastoma Multiforme (GBM)

S0927:Omega3-Fatty Acid Supp in Treating Muscle&Bone Pain&Stiffness in Pts W/Stg I,II,III Brst Canc Rec'v Hormone Thpy

3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection

Study of LY2784544 Testing Alternative Dosing in Participants With Myeloproliferative Neoplasms

A 12-Week Study in Asthmatic Children Ages 6 to <12 Years, Investigating the Efficacy and Safety of Symbicort pMDI 80/2.25 μg and Symbicort pMDI 80/4.5 μg, Compared With Budesonide pMDI 80 μg

Safety and Efficacy of Cariprazine for Bipolar I Disorder

Bipolar Disorder Study for Men and Women

A Study to Assess the Effect and Safety of AZD6765 in Patients With Major Depressive Disorder

Role of Exenatide in NASH-a Pilot Study

Efficacy and Safety of 20 mg Sumatriptan Powder Delivered Intranasally With the Bi-directional Device Compared With 100 mg Sumatriptan Tablets in Adults With Acute Migraine With or Without Aura

Progel Vascular Sealant

Prolonging Remission in Depressed Elderly (PRIDE)

Depression in Alzheimer's Disease-2